US fairness opinion providers
Q2 2026 · Fairness opinions on deals announced · 54 deals · US$266bn disclosed
| 1 | Goldman Sachs US$145bn · 16.7% share · new | 145,171.8 | 16.7% | New | |
| |||||
| 2 | Morgan Stanley US$56bn · 11.1% share · new | 56,282.7 | 11.1% | New | |
| |||||
| 3 | J.P. Morgan US$70bn · 9.3% share · new | 70,389.9 | 9.3% | New | |
| |||||
| 4 | BofA Securities US$67bn · 7.4% share · new | 66,924.0 | 7.4% | New | |
| |||||
| 4 | Evercore US$30bn · 7.4% share · new | 30,089.9 | 7.4% | New | |
| |||||
| 4 | Centerview Partners US$17bn · 7.4% share · new | 16,500.0 | 7.4% | New | |
| |||||
| 7 | Lazard US$65bn · 5.6% share · new | 65,433.0 | 5.6% | New | |
| |||||
| 7 | Piper Sandler 5.6% share · new | – | 5.6% | New | |
| | |||||
| 9 | Qatalyst Partners US$27bn · 3.7% share · new | 27,409.0 | 3.7% | New | |
| |||||
| 9 | Houlihan Lokey US$111m · 3.7% share · new | 110.8 | 3.7% | New | |
| |||||
| 9 | Performance Trust Capital Partners 3.7% share · new | – | 3.7% | New | |
| | |||||
| 12 | Allen & Company US$25bn · 1.9% share · new | 24,659.0 | 1.9% | New | |
| |||||
| 12 | PJT Partners US$18bn · 1.9% share · new | 17,600.0 | 1.9% | New | |
| |||||
| 12 | RBC Capital Markets US$17bn · 1.9% share · new | 17,000.0 | 1.9% | New | |
| |||||
| 12 | Jefferies US$11bn · 1.9% share · new | 10,900.0 | 1.9% | New | |
| |||||
| 12 | Moelis & Company US$8.5bn · 1.9% share · new | 8,500.0 | 1.9% | New | |
| |||||
| 12 | Rothschild & Co US$6.3bn · 1.9% share · new | 6,300.0 | 1.9% | New | |
| |||||
| 12 | Guggenheim Securities US$2.9bn · 1.9% share · new | 2,900.0 | 1.9% | New | |
| |||||
| 12 | Citi US$2.1bn · 1.9% share · new | 2,117.0 | 1.9% | New | |
| |||||
| 12 | Paradigm Capital US$1.9bn · 1.9% share · new | 1,900.0 | 1.9% | New | |
| |||||
| 12 | Leerink Partners US$739m · 1.9% share · new | 739.0 | 1.9% | New | |
| |||||
| 12 | Truist Securities US$535m · 1.9% share · new | 535.0 | 1.9% | New | |
| |||||
| 12 | Lucid Capital Markets US$414m · 1.9% share · new | 413.5 | 1.9% | New | |
| |||||
| 12 | VelocityHealth Securities US$100m · 1.9% share · new | 100.0 | 1.9% | New | |
| |||||
| 12 | Keefe, Bruyette & Woods US$81m · 1.9% share · new | 81.0 | 1.9% | New | |
| |||||
Top ten by number of deals.
This table's top firms in each year.
9 deals have no disclosed value. Q2 2025 rank is the firm's place in the same period a year earlier, under the same filters. Methodology









